Results 121 to 130 of about 2,720 (166)

Efficacy and safety of imipenem/cilastatin/relebactam (IMI/CS/REL): a meta-analysis of randomized controlled clinical trials. [PDF]

BMC Infect Dis
Lei W, Duan Y, Xin M, Tian M, Xu J.
europepmc   +1 more source

Nacubactam: a review on mechanistic insights and therapeutic promise for combating β-lactam resistance among multidrug-resistant Gram-negative pathogens. [PDF]

Ann Med Surg (Lond)
Kumar D, Kaur N, Surender, Aman S, Bibi A.   +4 more
europepmc   +1 more source

Emergence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae with Penicillin-Binding Protein 3 Insertions, Taiwan, 2021. [PDF]

Emerg Infect Dis
Long T, Lovey A, Sanborn L, Zhao Y, Bulman ZP, Lin YT, Chen L.   +6 more
europepmc   +1 more source

Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. [PDF]

Microbiol Spectr
Kim TY, Baek JY, Suh E, Lee J-K, Yu H-J, Ko J-H, Huh HJ, Lee NY.   +7 more
europepmc   +1 more source